These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17111159)

  • 1. Growth and PTH in prepubertal children on long-term dialysis.
    Cansick J; Waller S; Ridout D; Rees L
    Pediatr Nephrol; 2007 Sep; 22(9):1349-54. PubMed ID: 17111159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catch-up growth with normal parathyroid hormone levels in chronic renal failure.
    Waller S; Ledermann S; Trompeter R; van't Hoff W; Ridout D; Rees L
    Pediatr Nephrol; 2003 Dec; 18(12):1236-41. PubMed ID: 14586680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone and growth in children with chronic renal failure.
    Waller SC; Ridout D; Cantor T; Rees L
    Kidney Int; 2005 Jun; 67(6):2338-45. PubMed ID: 15882277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily on line haemodiafiltration promotes catch-up growth in children on chronic dialysis.
    Fischbach M; Terzic J; Menouer S; Dheu C; Seuge L; Zalosczic A
    Nephrol Dial Transplant; 2010 Mar; 25(3):867-73. PubMed ID: 19889872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S; Brandi L; Olgaard K
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of one haemodialysis treatment on the plasma concentrations of intact parathyroid hormone and ionised calcium: usefulness of end-dialysis values in evaluating the suppressibility of hyperparathyroidism.
    Pietilä K; Mustonen J; Mörsky P; Seppälä E; Pasternack A; Koivula T
    Nephrol Dial Transplant; 1989; 4(2):115-8. PubMed ID: 2496352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of haemodialysis on markers of bone turnover in children.
    Waller S; Ridout D; Rees L
    Pediatr Nephrol; 2007 Apr; 22(4):586-92. PubMed ID: 17216258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of rhGH in children with chronic kidney disease: lessons from NAPRTCS.
    Seikaly MG; Salhab N; Warady BA; Stablein D
    Pediatr Nephrol; 2007 Aug; 22(8):1195-204. PubMed ID: 17530299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bone and mineral disorder of children undergoing chronic peritoneal dialysis.
    Borzych D; Rees L; Ha IS; Chua A; Valles PG; Lipka M; Zambrano P; Ahlenstiel T; Bakkaloglu SA; Spizzirri AP; Lopez L; Ozaltin F; Printza N; Hari P; Klaus G; Bak M; Vogel A; Ariceta G; Yap HK; Warady BA; Schaefer F;
    Kidney Int; 2010 Dec; 78(12):1295-304. PubMed ID: 20811335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone during maintenance dialysis: influence of low calcium dialysate, plasma albumin and age.
    Heaf JG; Løkkegård H
    J Nephrol; 1998; 11(4):203-10. PubMed ID: 9702872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency.
    Hokken-Koelega A; Mulder P; De Jong R; Lilien M; Donckerwolcke R; Groothof J
    Pediatr Nephrol; 2000 Jul; 14(7):701-6. PubMed ID: 10912546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
    Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
    PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term recombinant human growth hormone use in Australian children with renal disease.
    Crompton CH;
    Nephrology (Carlton); 2004 Oct; 9(5):325-30. PubMed ID: 15504147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in children with chronic renal failure.
    Waller S; Ridout D; Rees L
    Pediatr Nephrol; 2007 Jan; 22(1):121-7. PubMed ID: 16977474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alphacalcidol oral pulses are effective in secondary hyperparathyroidism prior to dialysis.
    Koskimies O; Ala-Houhala M
    Clin Nephrol; 1996 Jul; 46(1):70-1. PubMed ID: 8832157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum levels of a non-(1-84) parathyroid hormone (PTH) fragment in pediatric haemodialysis patients.
    Salomon R; Charbit M; Gagnadoux MF; Niaudet P; Gao P; Cantor T; Souberbielle JC
    Pediatr Nephrol; 2001 Dec; 16(12):1011-4. PubMed ID: 11793090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of catch-up growth after kidney transplantation in children].
    Liao X; Li YJ; Tan JL; Zhang M; Zhong FZ; Wang CX; Qiu J; Fu Q; Liu LS; Gao Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):755-761. PubMed ID: 32669174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.